39.6
MiNK Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
20.4
FY23:
3.60
FY24:
4.99
FY25:
13.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.61
FY22:
1.07
FY23:
0.95
FY24:
0.73
FY25:
0.39
Total assets
Change from FY21 to FY25
millions USD
FY21:
40.2
FY22:
21.5
FY23:
4.55
FY24:
5.72
FY25:
14.2
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.5
FY22:
12.7
FY23:
11.4
FY24:
6.96
FY25:
13.0
(negative)
millions USD
FY21:
0
FY22:
9.19
FY23:
11.2
FY24:
18.3
FY25:
15.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
23.8
FY22:
−0.40
FY23:
−18.1
FY24:
−19.6
FY25:
−14.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
40.2
FY22:
21.5
FY23:
4.55
FY24:
5.72
FY25:
14.2
All amounts in millions USD